535217 — HPC Biosciences Balance Sheet
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
Annual balance sheet for HPC Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IAS | IAS | IAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 2.66 | 2.96 | 2.99 | 11.9 | 4.94 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 224 | 234 | 251 | 247 | 255 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 237 | 246 | 261 | 261 | 261 |
| Net Property, Plant And Equipment | 41.9 | 35.8 | 30.7 | 25.7 | 20.6 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 319 | 321 | 331 | 326 | 322 |
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.58 | 4.55 | 2.8 | 2.68 | 2.63 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 5.58 | 4.55 | 2.8 | 2.68 | 2.63 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 313 | 317 | 329 | 324 | 319 |
| Total Liabilities & Shareholders' Equity | 319 | 321 | 331 | 326 | 322 |
| Total Common Shares Outstanding |